A Human-First Discovery Approach: Leveraging Clinical Data to Identify Microbial Communities Driving Positive Clinical Outcomes

Time: 1:50 pm
day: Track B - Evening - Day One


  • Understand how they are utilizing data from human microbiota transplantation studies and machine learning to develop novel microbiome therapeutics and retire risk early
  • Hear an update on Finch’s clinical and preclinical pipeline
  • Listen to the latest clinical data supporting Finch’s lead product candidate, CP101, for the prevention of recurrent C. difficile infection